BOCA RATON, FL -- (MARKET WIRE) -- April 03, 2007 -- Vicor Technologies, Inc., a development-stage company and the developer of the PD2i Cardiac Analyzer, Vicor's patented device utilized in risk stratification of patients for Sudden Cardiac Death (SCD), announced the completion of its previously announced merger with and into SRKP 6, Inc. This transaction represents a significant step in Vicor's efforts to become a publicly traded company. Vicor expects to continue its present operations. In connection with the merger, SRKP 6, Inc. changed its name to Vicor Technologies, Inc.
